Nosocomial Burkholderia cepacia outbreak in an intensive pediatric care unit;Épidémie nosocomiale à Burkholderia cepacia dans une unité de réanimation infantile

Archives de Pediatrie

Volumn 10, Issue 10, 2003, Pages 882-886

  Bureau Chalot, F ^a   Piednoir, E ^a   Pierrat, C ^a   Santerne, B ^a   Bajolet, O ^a  

^a REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

Burkholderia cepacia; Cross infection; Disease outbreaks; Disinfection; Intensive care units, pediatric

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL DNA; DISINFECTANT AGENT; ANTIINFECTIVE AGENT;

ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; BURKHOLDERIA CEPACIA; CHILD; CLINICAL ARTICLE; CLONE; DISINFECTION; EPIDEMIC; FEMALE; GENOTYPE; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; MALE; NEWBORN INTENSIVE CARE; NONHUMAN; PATIENT CARE; RANDOM AMPLIFIED POLYMORPHIC DNA; RESPIRATORY TRACT INFECTION; BACTERIAL INFECTION; CASE REPORT; CROSS INFECTION; DISEASE TRANSMISSION; INTENSIVE CARE; ISOLATION AND PURIFICATION; MICROBIOLOGY; NEWBORN; PATHOGENICITY; PATHOLOGY;

ANTI-BACTERIAL AGENTS; BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTIONS; CHILD; CROSS INFECTION; DISEASE OUTBREAKS; DNA, BACTERIAL; FEMALE; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, PEDIATRIC; MALE; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; RESPIRATORY TRACT INFECTIONS;

EID: 0142056924     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(03)00452-4     Document Type: Article

References (23)

1. Husson MO, Hamze M, Verhille S, Izard D. Burkholderia. In: Freney J, et al. editors. Précis de bactériologie clinique. Paris: Eska; 2000. p. 1273-7.
2. Marty N, Segonds C, Chabanon G. Infections à Burkholderia cepacia: épidémiologie et résistance aux antibiotiques. Lett Infectiol 1998;5:203-7.
3. Drabick JA, Gracely EJ, Heidecker GJ, LiPuma JJ. Survival of Burkholderia cepacia on environmental surfaces. J Hosp Infect 1996;32:267-76.
4. Govan JRW, Hugues JE, Vandamme P. Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol 1996;45:395-407.
5. Segonds C, Chabanon G. Burkholderia cepacia: les dangers d'un micro-organisme phytopathogène pour les patients atteints de mucoviscidose. Ann Biol Clin (Paris) 2001;59:259-69.
6. Holmes A, Nolan R, Taylor R, Finley R, Riley M, Jiang R, et al. An epidemic of Burkholderia cepacia transmitted between patients with and without cystic fibrosis. J Infect Dis 1999;179:1197-205.
7. Siddiqui AH, Mulligan ME, Mahenthiralingam E, Hebden J, Brewrink J, Qaiyumi S, et al. An episodic outbreak of genetically related Burkholderia cepacia among non-cystic fibrosis patients at a university hospital. Infect Control Hosp Epidemiol 2001;22:419-22.
8. Mangram A, Jarvis WR. Nosocomial Burkholderia cepacia outbreaks and pseudo-outbreaks. Infect Control Hosp Epidemiol 1996;17:718-20.
9. Weems Jr JJ. Nosocomial outbreak of Pseudomonas cepacia associated with contamination of reusable electronic ventilator temperature probes. Infect Control Hosp Epidemiol 1993;14:583-6.
10. Berthelot P, Grattard F, Mahul P, Jospe R, Pozzeto B, Ros A, et al. Ventilator temperature sensors: an unusual source of Pseudomonas cepacia in nosocomial infection. J Hosp Infect 1993;25:33-43.
11. Takigawa K, Fujita J, Negayama K, Yamagishi Y, Yamaji Y, Ouchi K, et al. Nosocomial outbreak of Pseudomonas cepacia respiratory infection in immunocompromised patients associated with nebulizer devices. Kansenshogaku Zasshi 1993;67:1115-25.
12. Pegues CF, Pegues DA, Ford DS, Hibberd PL, Carson LA, Raine CM, et al. Burkholderia cepacia respiratory tract acquisition: epidemiology and molecular characterization of a large nosocomial outbreak. Epidemiol Infect 1996;116:309-17.
13. Hamill RJ, Houston ED, Georghiou PR, Wright CE, Koza MA, Cadle RM, et al. An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann Intern Med 1995;122:762-6.
14. Reboli AC, Koshinski R, Arias K, Marks-Austin K, Stieritz D, Stull TL. An outbreak of Burkholderia cepacia lower respiratory tract infection associated with contaminated albuterol nebulization solution. Infect Control Hosp Epidemiol 1996;17:741-3.
15. Ramsey AH, Skonieczny P, Coolidge DT, Kurzynski TA, Proctor M, Davis JP. Burkholderia cepacia lower respiratory tract infection associated with exposure to a respiratory therapist. Infect Control Hosp Epidemiol 2001;22:423-6.
16. van Laer F, Raes D, Vandamme P, Lammens C, Sion JP, Vrints C, et al. An outbreak of Burkholderia cepacia with septicemia on a cardiology ward. Infect Control Hosp Epidemiol 1998;19:112-3.
17. Pegues DA, Carson LA, Anderson RL, Norgard MJ, Argent TA, Jarvis WR, et al. Outbreak of Burkholderia cepacia in oncology patients. Clin Infect Dis 1993;16:407-11.
18. Anderson RL, Vess RW, Panlilio AL, Favero MS. Prolonged survival of Pseudomonas cepacia in commercially manufactured povidoneiodine. Appl Environ Microbiol 1990;56:3598-600.
19. Panlilio AL, Beck-Sague CM, Siegel JD, Anderson RL, Yetts SY, Clark NC, et al. Infections and pseudoinfections due to povidoneiodine solution contaminated with Pseudomonas cepacia. Clin Infect Dis 1992;14:1078-83.
20. Sobel JD, Hashman N, Reinherz G, Merzbach D. Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination. Am J Med 1982;73:183-6.
21. C-CLIN Paris-Nord. Guide de recommandations pour l'alimentation du nourrisson en collectivité pédiatrique. Paris: C-CLIN Paris-Nord; 1999. p. 32.
22. Okazaki M, Watanabe T, Morita K, Higurashi Y, Araki K, Shukuya N, et al. Molecular epidemiological investigation using a randomly amplified polymorphic DNA assay of Burkholderia cepacia isolates from nosocomial outbreaks. J Clin Microbiol 1999;37:3809-14.
23. Coenye T, Spilker T, Martin A, LiPuma JJ. Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III. J Clin Microbiol 2002;40:3300-7.